Advertisement Vyta and Bioagra settle foreclosure litigation - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Vyta and Bioagra settle foreclosure litigation

Vyta, a publicly held company with business activities in the electronic and biotechnology industries, has reached a favorable settlement in its foreclosure litigation against Bioagra, a manufacturer of all natural, non-toxic feed supplements.

Pursuant to the terms of the amicable agreement, Vyta now controls 100% ownership interest in Bioagra and Paul Metzinger, president and CEO of Vyta becomes the sole manager, and only executive officer of Bioagra.